AsiaⅠ型口蹄疫病毒VP1基因结构预测及亚细胞定位

利用PCR方法扩增到VP1基因，序列测定后利用Mega4．0、swiss—model、GOR4和RasMol软件预测了VP1基因的二、三级结构。将VP1基因融合EGFP基因后定向克隆入PcDNA3．1（＋）真核表达载体，构建正确的重组质粒命名为PVP1E，在脂质体介导下将PVP1E质粒转染BHK-21细胞，WesternBlotting试验证实VP1基因成功表达，经DAPI细胞核染色后在共聚焦显微镜下观察VP1亚细胞定位。结果表明本研究预测了VP1基因的二、三级结构，其在BHK-21细胞中呈现以细胞核为主的弥散性分布，VP1基因亚细胞定位及结构预测为进一步深入探究AsiaI型FMDVVP1结构和功能提供丰富的资料。     

兔病毒性出血症病毒次要结构蛋白（VP2）的表达和细胞内定位分析

病毒蛋白VP2是兔出血症病毒（Rabbit Hemorrhagic Disease Virus,RHDV）的一种次要结构蛋白。本文旨在构建VP2与绿色荧光蛋白融合的真核表达载体,进而利用它研究VP2在细胞内的定位情况。首先在大肠杆菌中表达GST-VP2融合蛋白,然后用纯化的重组蛋白免疫小鼠制备抗VP2的抗血清。对制备的抗VP2抗血清进行特异性分析,再利用该抗体对转染pEGFP-VP2的BHK-21细胞进行检测,以研究VP2蛋白在细胞内的定位情况。结果表明,pEGFP-VP2转染BHK-21细胞后,不仅VP2蛋白得到了成功表达,而且通过检测偶联的绿色荧光蛋白可判断出VP2蛋白主要分布于BHK-21细胞的细胞质。本研究成功构建了VP2与绿色荧光蛋白融合的表达载体,并在真核细胞内实现了表达,通过检测荧光蛋白,发现VP2主要在细胞质内表达并分布,为深入探讨VP2的生物学功能奠定了基础。     

犬细小病毒VP2蛋白的原核表达与纯化

为了研究犬细小病毒（canine parovirus,CPV）VP2蛋白的结构和功能,本试验对CPV VP2蛋白进行表达和纯化。采用大肠杆菌表达外源蛋白的方法,将CPV VP2基因插入原核表达载体pET-32a（+）中构建重组原核表达载体pET-VP2,转化至大肠杆菌BL21（DE3）感受态细胞中,在不同IPTG浓度、诱导温度和诱导时间条件下进行原核表达,确定最佳诱导条件。最佳条件下的诱导产物经超声破碎离心后,利用镍柱对重组蛋白进行纯化并用SDS-PAGE和Western blotting进行双重鉴定。结果显示,重组质粒pET-VP2经双酶切鉴定分别获得大小为5 900 bp左右的载体条带和1 755 bp左右的目的基因条带,成功构建了pET-VP2重组质粒;重组VP2蛋白的分子质量约为64 ku,与预期大小一致,且在37℃、1.0 mmol/L IPTG、诱导5 h条件下表达量最高,条带最亮;蛋白超声破碎后经SDS-PAGE发现,只在沉淀中出现了目的条带,而上清中并未出现相应条带,说明重组蛋白均以包涵体的形式存在;纯化后获得的重组蛋白,经SDS-PAGE和Western blotting双重鉴定,均在64 ku处出现条带,说明纯化后的蛋白为重组蛋白pET-VP2。本试验通过对CPV VP2蛋白的原核表达及纯化成功获得了大量纯度较高的CPV VP2蛋白,为今后制备CPV VP2蛋白多克隆抗体及进一步研究该蛋白在对治疗犬细小病毒病中的临床应用价值提供了基础理论依据。     

The alcelaphine herpesvirus-1 ORF 57 encodes a nuclear shuttling protein

Alcelaphine herpesvirus-1 (AlHV-1) is a γ₂ rhadinovirus associated with Malignant Catarrhal Fever (MCF) in cattle. ORF 57 is well conserved among gammaherpesviruses and it has been shown that the ORF 57 gene products of Herpesvirus Saimiri (HVS), Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) play an important role in regulating viral gene expression. The AlHV-1 ORF 57 gene product has not been characterized. In the accompanying paper we have demonstrated that AlHV-1 ORF 57 encodes an immediate early protein that acts as a regulator of gene expression. The ORF 57 gene product has an up-regulatory effect only on another immediate early gene product encoded by ORF 50. Here we show that the ORF 57 gene product is a nuclear protein. When ORF 57 was fused to the gene encoding Enhanced Green Fluorescent Protein (EGFP), the fusion protein exhibited a punctate nuclear distribution that co-localized with the nucleolar phosphoprotein C23. The nuclear localisation signal of ORF 57 gene product was located at the N-terminus. The ORF 57 gene product travels from nucleus to the cytoplasm, where it accumulates during Actinomycin D treatment. The domain involved in nuclear shuttling was also localised at the N-terminal region of the protein. Thus in common with homologues in other herpesviruses the AlHV-1 ORF 57 gene product is a nuclear cytoplasmic shuttling protein which may play a role in export of viral mRNAs from the nucleus of infected cells.     

犬细小病毒VP2抗体竞争ELISA检测方法的初步建立

本研究旨在制备犬细小病毒(canine parvovirus,CPV)VP2抗体,并建立竞争ELISA检测方法,从而为CPV疫苗免疫效果的检测及血清学调查提供技术支持。参照GenBank中犬细小病毒VP2基因序列设计1对添加EcoR Ⅰ和Xho Ⅰ酶切位点的引物,PCR扩增VP2基因全长序列,将其克隆到pET28a(＋)载体中,构建原核表达载体pET28a-VP2,转化大肠杆菌Rosetta,表达并纯化了重组蛋白。SDS-PAGE及Western blotting分析表明,目的蛋白分子质量大小为67 ku,可被CPV抗血清识别,证明其能与特异性抗体结合,有良好的抗原性。以纯化的重组蛋白免疫家兔制备VP2多抗,采用辣根过氧化物酶进行标记,初步建立了竞争ELISA方法。结果显示,VP2重组蛋白的最佳包被浓度为5 μg/mL,酶标多抗的最佳稀释度为1∶3200,封闭条件为4 ℃过夜,最适的封闭液为10%小牛血清,山羊抗兔IgG-HRP的最佳工作浓度为1∶5000,显色时间为25 min。竞争ELISA试验结果表明,该方法具有较强的稳定性,有望为CPV疫苗免疫效果的判定及血清学调查提供技术手段。     

犬细小病毒DD株的分离鉴定和VP2基因序列分析

本实验室对从疑似犬细小病毒感染的发病犬分离的病毒采用同步培养法接种猫肾细胞（CRFK）增殖,通过PCR试验、IFA试验和VP2基因测序分析等方法进行鉴定并分型,获得一株犬细小病毒强毒株,命名为CPV-DD株。对分离病毒进行PCR扩增,可扩增出特异性DNA片段（1 163 bp）;盲传至第6代时,病毒液的HA效价为1∶1...     

猪细小病毒VP2蛋白病毒样颗粒在伪狂犬病病毒表达系统中的表达

利用PCR技术从猪细小病毒（PPV）SC1株基因组中扩增VP2全基因,并将其插入真核表达载体pPI-2.EG-FP中,构建转移载体pPI-2.EGFP.VP2。采用脂质体介导法将猪伪狂犬病病毒（PRV）SA215株DNA与pPI-2.EGFP.VP2DNA共转染Vero细胞,待出现细胞病变后收集病毒液。经空斑纯化,并同时采用检测PPV VP2基因的PCR方法筛选获得重组病毒PRV SA215/VP2株。以兔抗VP2的多克隆抗体建立的免疫荧光技术可检测到Vero细胞发出的特异性荧光,表明PPV VP2成功插入到PRV SA215基因组中,并获得表达。进一步电镜观察表明,感染PRV SA215/VP2的Vero细胞中可同时观察到PRV与PPV 2种类病毒样颗粒。结果表明,成功实现了利用PRV载体表达PPV VP2蛋白病毒样颗粒,为进一步研制PPV病毒样颗粒疫苗奠定了基础。     

Fluorescent tagging of VP22 in N-terminus reveals that VP22 favors Marek’s disease virus (MDV) virulence in chickens and allows morphogenesis study in MD tumor cells

Marek’s disease virus (MDV) is an alpha-herpesvirus causing Marek’s disease in chickens, mostly associated with T-cell lymphoma. VP22 is a tegument protein abundantly expressed in cells during the lytic cycle, which is essential for MDV spread in culture. Our aim was to generate a pathogenic MDV expressing a green fluorescent protein (EGFP) fused to the N-terminus of VP22 to better decipher the role of VP22 in vivo and monitor MDV morphogenesis in tumors cells. In culture, rRB-1B EGFP22 led to 1.6-fold smaller plaques than the parental virus. In chickens, the rRB-1B EGFP22 virus was impaired in its ability to induce lymphoma and to spread in contact birds. The MDV genome copy number in blood and feathers during the time course of infection indicated that rRB-1B EGFP22 reached its two major target cells, but had a growth defect in these two tissues. Therefore, the integrity of VP22 is critical for an efficient replication in vivo, for tumor formation and horizontal transmission. An examination of EGFP fluorescence in rRB-1B EGFP22-induced tumors showed that about 0.1% of the cells were in lytic phase. EGFP-positive tumor cells were selected by cytometry and analyzed for MDV morphogenesis by transmission electron microscopy. Only few particles were present per cell, and all types of virions (except mature enveloped virions) were detected unequivocally inside tumor lymphoid cells. These results indicate that MDV morphogenesis in tumor cells is more similar to the morphorgenesis in fibroblastic cells in culture, albeit poorly efficient, than in feather follicle epithelial cells.     

Preparation and Identification of Canine Parvovirus NY Strain VP2 Protein Polyclonal Antibody

This study was aimed to prepare canine parvovirus (CPV) VP2 protein polyclonal antibody.The recombinant expression vector pET28a-CPV-VP2 was constructed and transfromed into E.coli BL21 (DE3),the expression of recombinant proteins was induced by IPTG from which the fusion protein was identified by SDS-PAGE.The target protein was purified and emulsify with adjuvant,the prepared immunogen was inoculated into rabbit by subcutaneous injections to prepare of VP2 protein specific polyclonal antibody.The immuno-activity,titers,neutralization titers of the prepared polyclonal antibody were determined by immunoperoxidase monolayer assay (IPMA).The results showed that the expressed recombinant protein VP2 (rVP2) existed in the form of inclusion body with a molecular weight of 72 ku.The prepared polyclonal antibody titer was 1 600 dilution,the virus titer was 10⁷ TCID₅₀/mL,the neutralizing titer was 1∶2 884.The antibodies showed specific reaction with CPV.In conclusion,rVP2 specific polyclonal antibody showed wonderful immunocompetence,specificity and neutralizing activity,providing foundation for the development of genetic vaccine and clinical therapeutic method.     

贵阳地区犬细小病毒VP2基因的克隆及遗传进化分析

为研究贵阳地区犬细小病毒（canine parvovirus,CPV）的流行基因型及其遗传进化情况,本试验对从贵阳市分离的10株CPV的VP2基因进行PCR扩增和克隆并进行序列分析。结果显示,分离的病毒能使F81猫肾细胞产生明显的细胞病变（CPE）,分离的10株病毒中,7株为CPV-2a亚型,3株为CPV-2c亚型,命名为GY-1~GY-10。10株CPV分离株与疫苗株VP2基因的同源性98.4%~99.4%,与其他国内外参考株的同源性为97.7%~99.9%。本试验首次报道贵阳市CPV的流行基因型为CPV-2a亚型并伴随CPV-2c亚型存在,对监测CPV遗传变异趋势及疫苗的研制具有重要意义。     

Cloning and Phylogenetic Analysis of VP2 Gene of Canine Parvovirus in Guiyang Area

This study was aimed to investigate popular genotype and phylogenesis of VP2 gene of canine parvovirus (CPV) in Guiyang area. Ten strains of viruses were isolated from Guiyang and the VP2 gene was amplified by PCR, cloned and sequenced. Results showed that the isolate virus grew could produce typical CPE in F81 cells, seven strains of CPV were CPV type 2a and others were CPV type 2c, named as GY-1 to GY-10. The nucleotide homologies of the isolated strains compared with 3 vaccine strains were 98.4% to 99.4%, with others reference strains nucleotide homologies within 97.7% to 99.9%.This research firstly reported the prevalence of CPV genotype was CPV type 2a in Guiyang area with such CPV type 2c, this was very important for monitoring the trend of CPV genetic variation and the development of vaccine.     

犬细小病毒NY株VP2蛋白多克隆抗体的制备与鉴定

试验旨在制备犬细小病毒（canine parvovirus,CPV）VP2蛋白多克隆抗体。构建pET28a-CPV-VP2重组表达质粒转化大肠杆菌BL21（DE3）感受态细胞,经IPTG诱导,SDS-PAGE鉴定融合蛋白的表达,纯化目的蛋白与佐剂混合、乳化制备后作为免疫原,免疫家兔制备VP2蛋白多克隆抗体;采用免疫过氧化物酶单层细胞染色法（immunoperoxidase monolayer assay,IPMA）检测抗体的免疫活性、抗体滴度、病毒滴度及中和活性。结果表明,重组VP2蛋白（rVP2）以包涵体形式存在,分子质量约为72 ku;所制备的多克隆抗体滴度为1 600倍,病毒滴度为10⁷ TCID₅₀ /mL,中和效价为1∶2 884,该抗体与体外培养的CPV呈特异性反应,CPV VP2蛋白的多克隆抗体免疫活性和特异性良好,且中和活性高,为CPV基因工程疫苗的研究和临床治疗奠定了基础。     

白细胞介素-12对犬细小病毒VP2 DNA疫苗的免疫增强作用

犬细小病毒编码的VP2蛋白是该病毒重要的结构蛋白和抗原蛋白。利用VP2基因制备的DNA疫苗能够刺激机体产生免疫应答反应。为进一步提高VP2DNA疫苗的免疫应答水平,本研究在小鼠体内尝试了利用白细胞介素12（IL-12）基因表达载体提高VP2DNA疫苗的免疫应答水平。首先采用RT-PCR方法从小鼠脾淋巴细胞中分别扩增IL-12大亚基（P40）和小亚基（P35）cDNA基因;然后在真核表达载体pcDNA3.1A上通过引入内部核糖体进入位点（IRES）序列,分别将P40基因和P35基因插入到IRES序列的上下游,构建成IL-12（P40和P35双亚基）基因表达载体,pcDNA-P40-IRES-P35。将上述表达载体与本室构建的VP2表达载体通过磷酸钙方法转染HEK 293T细胞进行瞬时表达,以确定构建的表达载体能否介导相应基因在真核细胞中进行分泌表达。然后用VP2载体单免疫和VP2载体和IL-12载体共免疫方法对小鼠进行免疫（用pcDNA3.1A作为对照）。免疫后在特定时间通过ELISA方法检测小鼠血清抗VP2蛋白的抗体水平,并通过淋巴细胞增殖实验检测免疫后35d小鼠脾脏淋巴细胞增殖反应。结果表明,扩增的小鼠IL-12P40和P35亚基基因与GenBank的参考序列基本一致。Western-blot检测结果表明,重组IL-12和VP2均能够在HEK293T细胞中进行分泌性表达。ELISA检测结果表明利用IL-2载体与VP2载体共免疫小鼠,其血清中抗VP2的抗体水平明显高于VP2载体单免疫组（P〈0.01）,抗体水平在第35天高达1：5120。淋巴细胞增殖试验结果表明,免疫小鼠的淋巴细胞刺激指数均明显高于对照组（P〈0.01）,VP2载体与IL2载体共免疫组的刺激指数明显高于VP2载体单免疫组（P〈0.05）。由此可见,在小鼠体内,IL-12基因表达载体可明显提高CPV VP2基因疫苗的免疫应答水平。     

抗蓝舌病病毒VP6和VP7蛋白单克隆抗体的制备及鉴定

为制备针对蓝舌病病毒(BTV)的单克隆抗体(MAb),本研究利用血清型1型BTV(BTV1)免疫BALB/c鼠,将其脾淋巴细胞与SP2/0进行融合,并用BTV1包被ELISA板,通过间接ELISA方法筛选出3株稳定分泌抗BTV1的MAb的杂交瘤细胞株(2B10、3D4和4H8)。利用表达BTV1主要蛋白的真核表达重组质粒转染BHK-21后,对所制备的杂交瘤细胞株上清进行间接免疫荧光(IFA)以及western blot鉴定,结果显示:2B10和4H8与VP7蛋白反应,而3D4与VP6蛋白反应。同时,IFA鉴定结果进一步表明,3株MAb与24个血清型的BTV均可以发生反应。本研究制备的MAb为建立BTV免疫学检测方法和相关病毒蛋白的功能研究奠定了基础。     

鸡贫血病毒衣壳蛋白VP1基因的克隆、原核表达和纯化

根据GenBank中CAV哈尔滨分离株基因序列,设计出针对CAV VP1大片段(608 bp)的引物,利用PCR方法从CAV基因组序列中扩增出VP1基因的大片段(608 bp),按照正确的读码框克隆到原核表达载体pET32a( )上,得到含VP1大片段的pET32a( )重组子,转化大肠埃希菌BL21(DE3)感受态细胞,IPTG诱导重组蛋白表达,经SDS-PAGE和Western blotting检测发现有分子质量约42 ku的融合蛋白表达,与预期分子质量大小一致,通过Ni亲和层析柱纯化出融合蛋白,经Western blotting鉴定,融合蛋白与His单抗能够结合.CAV VP1基因的克隆表达及其融合蛋白的纯化为后续制备多克隆抗体和单克隆抗体提供了良好的抗原来源,也为研究VP1与其他CAV蛋白之间的相互关系奠定了基础.     

南宁地区犬细小病毒VP2基因的克隆及遗传进化分析

为了解广西南宁地区犬细小病毒（CPV）的流行现状与病毒变异情况,本试验对初步确诊为犬细小病毒病的12份阳性病料提取基因组DNA,以提取的基因组DNA为模板,通过PCR扩增VP2基因序列并测序,将12个阳性毒株样本VP2基因测序结果与GenBank中登录的17株国内外CPV分离株VP2基因进行同源性比对,采用Mega 7.0软件绘制遗传进化树,分析其病毒亚型和遗传进化情况。结果显示,成功扩增得到12个毒株样本的VP2基因片段,大小约1 755 bp,12株阳性样本毒株的VP2基因同源性在99.2%~100.0%之间,其中NN01与NN07、NN02与NN06同源性最高,为100.0%;阳性样本毒株与国内其他分离株VP2基因的同源性为97.6%~100.0%,其中NN08、NN10及NN04与CPV-ZJ1579同源性最高,均为100.0%,属于CPV-2a亚型;阳性样本毒株与国外代表性毒株同源性在98.1%~99.8%之间。遗传进化树分析表明,12个样本毒株中有3株属于CPV-2a亚型,3株属于CPV-2b亚型,6株属于CPV-2c亚型。这是继2018年初广西分离到CPV-2c型CPV后,首次发现南宁地区大规模流行CPV-2c亚型病毒,预示着CPV-2c亚型CPV在国内的流行正在增加。综上所述,广西南宁地区CPV-2a、CPV-2b与CPV-2c亚型并存,但CPV-2c亚型的比重比其他地区大,这也给该地区提供了新的防治信息,在实际CPV防控工作中除了对CPV-2a、CPV-2b等传统流行亚型的关注之外,更应该重视CPV-2c亚型CPV的防控。     

白细胞介素-2基因表达质粒对犬细小病毒VP2DNA疫苗在小鼠的免疫增强作用

犬细小病毒编码的VP2蛋白是该病毒主要抗原蛋白。研究证实由VP2基因制备的DNA疫苗能够刺激机体产生免疫应答反应。为提高VP2DNA疫苗的免疫原性,本研究在小鼠体内尝试了利用犬白细胞介素2（cIL-2）基因增强VP2DNA疫苗免疫应答的研究。通过RT-PCR方法从犬脾淋巴细胞中分别扩增含终止密码子和不合终止密码子的cIL-2cDNA基因,然后将基因插入到真核表达载体pcDNA3．1中,分别构建成非融合的和与Myc／His融合的clL-2基因真核分泌型表达载体,pcDNA-cIL-2和pcDNA-cIL-2／MH。将pcDNA-oIL-2／MH表达栽体通过磷酸钙方法转染HEK293T细胞进行瞬时表达,以确定构建的表达栽体能否介导cIL-2在真核细胞中进行分泌表达。然后用VP2表达载体（pcDNA-CD5sp-VP2,本室构建）单注射和VP2／IL-2表达载体共注射对小鼠进行免疫（用pcD-NA3．1栽体作为阴性对照）。免疫后通过ELISA方法检测免疫后不同时期小鼠血清VP2的抗体水平,并通过细胞增殖试验检测免疫后小鼠脾脏淋巴细胞的增殖反应,用ELISA方法测定小鼠淋巴细胞γ干扰素的表达水平。试验结果表明,扩增的小鼠cIL-2基因与GenBank的参考序列一致,构建的cIL-2表达载体能够介导重组cIL-2在HEK293T细胞中进行分泌表达。免疫结果显示,利用cIL-2／VP2表达载体共免疫小鼠,免疫后35d血清中VP2的抗体水平达到1：5120,明显高于VP2表达载体单免疫组（P〈0．01）。淋巴细胞增殖试验表明,2组免疫小鼠的淋巴细胞刺激指数均明显高于阴性对照组（P〈0．01）,共免疫组的刺激指数又明显高于单免疫组（P〈0．05）。共免疫小鼠淋巴细胞7干扰素的表达水平明显高于单免疫组和阴性对照组（P〈0．01）。由此可见,cIL-2表达载体可明显提高CPVVP2基因疫苗的免疫应答水平。     

Prokaryotic Expression and Immunoreactivity Analysis of VP2 Protein of Bluetongue Virus Serotype 1

The study was aimed to test the immunoreactivity of the VP2 protein of bluetongue virus serotype 1 (BTV-1) in vitro. Based on the published BTV-1 L2 gene of Y863 strain, specific cloning PCR primers were designed and synthesized. The L2 gene was amplified through RT-PCR method and then was purified and cloned into the expressing vector pEASY-Blunt E1. The cloned recombinant plasmids were identified. The positive recombinant L2 plasmid was cloned into BL21(DE3) competent cells to express VP2 protein. The acquired purified recombinant BTV-1 VP2 protein was analyzed through the methods of Western blotting, ELISA and blocking ELISA. The results showed that:BTV-1 VP2 protein was expressed as the inclusion bodies in the pEASY-Blunt E1 vector; 160 and 200 mmol/L glyoxaline were the best condition to wash down the expressed protein. The molecular weight of this purified recombinant protein with N-terminal His-tag was about 105 ku. Through the results of Western blotting, ELISA and blocking ELISA, it had been proved that this recombinant protein could combine with BTV-1 specific antibody and this combination could be blocked by BTV-1 virus. The study showed that the recombinant BTV-1 VP2 protein, expressed through the prokaryotic expression vector pEASY-Blunt E1, possessed good immunoreactivity and this study had established foundation for locating the serotypic epitopes of the BTV-1 VP2 protein.     

犬细小病毒昆明流行株的分离鉴定与VP2基因序列分析

为了解昆明市犬细小病毒(canine parvovirus,CPV)流行及抗原变异情况,有针对性地筛选疫苗及研发新疫苗,本研究从昆明市部分宠物医院收集6份疑似CPV粪便样品进行病毒分离培养,对获得的疑似病毒液进行PCR、免疫荧光试验(IFA)、血凝效价测定、TCID50测定及VP2基因序列分析。结果显示,分离的1株病毒能使F81猫肾细胞产生明显的细胞病变(CPE),PCR扩增产物大小为164bp,IFA鉴定感染的F81细胞出现绿色荧光,血凝效价为1∶512,病毒TCID50为10-4.375/0.1mL,VP2基因PCR扩增条带大小为1 755bp。对分离株VP2结构蛋白进行测序分析,判定该分离株为CPV-2a亚型,与标准毒株存在5个变异氨基酸位点,属于变异株。将测序结果与商品化疫苗株及国内参考株序列进行比对分析,结果显示与弱毒苗Intervet/vaccine/06和Pfizer/vaccine/06核苷酸同源性均为98.7%;与国内参考毒株序列同源性为98.2%～99.5%,与ANTU-1和WH02/06株同源性最高;与ANTU-1株、WH02/06株及BJ01株亲缘关系最近,位于进化树的同一簇。本研究对监测CPV的遗传变异趋势及疫苗的研制具有重要意义。     

蓝舌病1型病毒VP2蛋白的原核表达及免疫反应性分析

试验旨在研究蓝舌病1型病毒（bluetongue virus serotype 1,BTV-1） VP2蛋白体外表达产物免疫反应性。根据已发表的BTV-1 Y863毒株L2基因序列设计合成特异性BTV-1 PCR引物,通过RT-PCR方法扩增L2基因,将纯化的L2基因克隆至pEASY-Blunt E1表达载体,对重组质粒进行鉴定,将阳性重组质粒L2克隆至大肠杆菌BL21（DE3）感受态细胞进行表达,对获得的纯化的BTV-1 VP2重组蛋白进行Western blotting、ELISA、阻断ELISA分析。结果显示,BTV-1 VP2蛋白在pEASY-Blunt E1载体上以包涵体形式表达,通过Ni-NTA亲和层析,160和200 mmol/L咪唑是洗脱BTV-1 VP2蛋白表达产物的最佳浓度。纯化获得N末端携带多聚组氨酸标签的BTV-1 VP2重组蛋白,分子质量约105 ku,Western blotting、ELISA、阻断ELISA结果显示,重组BTV-1 VP2蛋白能与BTV-1型特异性抗体发生特异性结合,且此结合能被BTV-1阻断。本试验结果表明,通过原核表达载体pEASY-Blunt E1表达的BTV-1 VP2重组蛋白具有良好的免疫反应性,为BTV-1 VP2蛋白型特异性表位定位研究奠定了基础。